Aurobindo Pharma Ltd's wholly-owned step-down subsidiary, CuraTeQ Biologics, has received marketing authorisation from the European Commission for its trastuzumab biosimilar, Dazublys.This regulatory milestone follows...
Shares of Sun Pharmaceuticals Ltd., India's largest drugmaker, and its unit Sun Pharma Advanced Research Company (SPARC) will be in focus on Wednesday, June...